Robert F. Lodato

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.

Robert G. Kilbourn, Steven S. Gross, Amal Jubran et al. · Proceedings of the National Academy of Sciences · 1990 · 654 citations · Full text

Excess L-arginine, Hypertension, Nitric Oxide +16

Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis

Robert G. Kilbourn, Amal Jubran, Steven S. Gross et al. · Biochemical and Biophysical Research Communications · 1990 · 557 citations

Biochemistry, Reactive Nitrogen Specie, Medicine +7

N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin.

Justin Cobb, Charles Natanson, William D. Hoffman et al. · The Journal of Experimental Medicine · 1992 · 249 citations · Full text

Pharmacotherapy, Mortality Rates, Oxidative Stress +16

Variability of resting respiratory drive and timing in healthy subjects

Martin J. Tobin, M. Jeffery Mador, S. M. Guenther et al. · Journal of Applied Physiology · 1988 · 244 citations

Asthma, Healthy Subjects, Motor Control +16

Administration of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)*

Jan Bakker, Robert F. Grover, Angela McLuckie et al. · Critical Care Medicine · 2004 · 194 citations